Merrimack Pharmaceuticals Stock Analysis

Merrimack Stock Analysis Notes

About 67.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.07. Merrimack Pharmaceuticals recorded a loss per share of 0.08. The entity last dividend was issued on the 13th of December 2019. The firm had 1271:1000 split on the 6th of September 2019. Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Merrimack Pharmaceuticals contact Richard Peters at 617 720 8606 or learn more at https://www.merrimack.com.

Merrimack Pharmaceuticals Investment Alerts

Merrimack Pharmaceuticals Upcoming and Recent Events

Merrimack Largest EPS Surprises

View All Earnings Estimates

Merrimack Pharmaceuticals Thematic Classifications

Merrimack Stock Institutional Investors

Note, although Merrimack Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Merrimack Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 213.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merrimack Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Merrimack Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Merrimack Profitablity

Management Efficiency

Merrimack Pharmaceuticals has return on total asset (ROA) of (0.0697) % which means that it has lost $0.0697 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0622) %, meaning that it created substantial loss on money invested by shareholders. Merrimack Pharmaceuticals' management efficiency ratios could be used to measure how well Merrimack Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.06. Return On Capital Employed is expected to rise to -0.11 this year. Change To Liabilities is expected to rise to about 25.5 K this year, although the value of Total Current Liabilities will most likely fall to about 418.9 K.

Technical Drivers

As of the 23rd of April, Merrimack Pharmaceuticals secures the Downside Deviation of 0.6775, risk adjusted performance of 0.0951, and Mean Deviation of 0.5876. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Merrimack Pharmaceuticals, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to break down nineteen technical drivers for Merrimack Pharmaceuticals, which can be compared to its peers in the industry. Please verify Merrimack Pharmaceuticals variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Merrimack Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 14.73 per share. Given that Merrimack Pharmaceuticals has jensen alpha of 0.2037, we recommend you to check Merrimack Pharmaceuticals's last-minute market performance to make sure the company can sustain itself at a future point.

Merrimack Pharmaceuticals Price Movement Analysis

Merrimack Pharmaceuticals Insider Trading Activities

Merrimack Pharmaceuticals Predictive Daily Indicators

Merrimack Pharmaceuticals Corporate Filings

Merrimack Pharmaceuticals Forecast Models

Merrimack Pharmaceuticals' time-series forecasting models are one of many Merrimack Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Merrimack Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Merrimack Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Merrimack shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Merrimack Pharmaceuticals. By using and applying Merrimack Stock analysis, traders can create a robust methodology for identifying Merrimack entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Merrimack analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Merrimack analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Merrimack Pharmaceuticals stock analysis indicators help investors evaluate how Merrimack Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Merrimack Pharmaceuticals shares will generate the highest return on investment. By understating and applying Merrimack Pharmaceuticals stock analysis, traders can identify Merrimack Pharmaceuticals position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merrimack Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.